You searched for "regulation"
SightCare Conference 2023
The SightCare conference brings independent optical practice’s together on 29 and 30 January 2023 at the Telford International Centre to network with their colleagues and peers and enjoy two days of workshops, keynote speakers, CPD education, learning and fun. This...Moorfields Education: EyeThrive: Ophthalmic leadership and management programme
Two-day course 10 and 13 November 2023RCOphth Supervision for Ophthalmic Practitioner Training
The Royal College of Ophthalmologists Training The Trainer - Supervision for Ophthalmic Practitioner TrainingLothian Optometry Teach and Treat Clinic
The Lothian Optometry Teach and Treat (LOTT) Clinic is a supervised training clinic for community optometrists with an interest in managing patients with acute eye pathology, normally managed in the hospital setting. LOTT, which is the first clinic of its...My message to future ophthalmology teaching fellows: Organising an effective ophthalmology placement
Globally, teaching ophthalmology during the undergraduate period presents challenges. The time allocated for it is minimal with substandard exposure [1,2]. Additionally, the number of universities mandating formal ophthalmology education has significantly declined [3]. Research supports the observation that doctors in...See sweet to C-suite: Peter Holland
See also - See sweet to C-suite: Imran Rahman In this three-part conversation series, Co-editor David Lockington speaks with highly influential individuals about their journey to the top, with advice for the next generation of leaders. Part One: David speaks...Working smarter not harder: How to transform eyecare delivery in the United Kingdom (part 1)
Are we doing enough to meet the current demands on ophthalmic services? In part one of a two-part series (see Part 2 here), Rosalind Harrison takes a look at how efficiency has been improved in eyecare services in the US....
Efficacy and safety of novel PF brimonidine / timolol fixed-combination ophthalmic solution for OAG
This study is a multicentre, randomised, open-label, parallel-group clinical trial to evaluate the efficacy and safety of a newly developed preservative-free (PF) brimonidine / timolol fixed-combination (BTFC) ophthalmic solutions as compared with preservative-containing (PC) BTFC ophthalmic solution in adult patients...Neurofibromatosis type 2 – diagnosis, features and MDT approach
NF2 is a genetic condition caused by mutation in a single gene (NF2 gene) on chromosome 22. The NF2 gene provides instructions to produce a protein called merlin, also known as schwannomin. This protein functions as a tumour suppressor, preventing...
